News Daily News Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains Caitlin E. Cox December 31, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2025 Caitlin E. Cox November 03, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News ESC 2025 ESC/EACTS Release New Valvular Heart Disease Guidelines Yael L. Maxwell September 03, 2025
News Daily News Money Talk: Cardiologists Must Weigh Costs as Transcatheter Therapies Ascend Caitlin E. Cox August 11, 2025
News Conference News STS 2025 Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’ Yael L. Maxwell February 05, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2024 Caitlin E. Cox September 03, 2024
News Daily News STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios Yael L. Maxwell May 01, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024
News Conference News TCT 2023 More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact Yael L. Maxwell October 24, 2023
News Daily News US and European Valvular Guidelines Mostly Concordant, Analysis Finds L.A. McKeown August 21, 2023
News Conference News TVT 2023 Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes Michael O'Riordan June 13, 2023
News Daily News Similar Outcomes in Men and Women After Transcatheter Tricuspid Interventions Michael O'Riordan April 05, 2023
News Conference News PCR London Valves 2022 Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing Shelley Wood December 07, 2022
News Daily News Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women L.A. McKeown November 21, 2022
News Conference News TCT 2022 Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID Michael O'Riordan September 17, 2022
News Daily News Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes Michael O'Riordan September 13, 2022